Picard Medical, Inc. (PMI): Nasdaq/NYSE listing notice — Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity

Picard Medical, Inc.

Gross proceeds of $5.0M from sale of ~16.7M shares (or pre-funded warrants) and Series A/B warrants at $0.30 per unit.
Proceeds used for working capital and debt repayment; offering closed May 6, 2026.
NYSE American notified stockholders' equity of $3.8M as of Dec 31, 2025 is below $4M threshold; PMI must submit compliance plan by June 7, 2026.
Regain compliance deadline Nov 8, 2027; stock continues trading with '.BC' indicator.
Company directors and officers subject to 30-day lock-up; 60-day company restriction on further issuance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Picard Medical, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(ii)

Exact text from the filing

May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Picard Medical, Inc. entered into Placement Agency Agreement with WestPark Capital, Inc. valued at 7.0% of the gross proceeds of the Offering (effective 2026-05-05).

Action: entry
Agreement: underwriting
Counterparty: WestPark Capital, Inc.
Value: 7.0% of the gross proceeds of the Offering
Effective: 2026-05-05

Exact text from the filing

WestPark Capital, Inc. acted as the sole placement agent (the “Placement Agent”) in connection with the Offering pursuant to a placement agency agreement, dated May 5, 2026, by and between the Company and the Placement Agent (the “Placement Agency Agreement”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Picard Medical, Inc. entered into Purchase Agreement with certain investors valued at aggregate of approximately $5.0 million (effective 2026-05-05).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: aggregate of approximately $5.0 million
Effective: 2026-05-05

Exact text from the filing

Certain of the investors purchased their Offered Shares and Common Warrants pursuant to a securities purchase agreement dated May 5, 2026 by and among the Company and such investors (the “ Purchase Agreement ”).

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Picard Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-004960

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.